Literature DB >> 8626021

Targeted disruption in the mouse Hoxc-4 locus results in axial skeleton homeosis and malformation of the xiphoid process.

H Saegusa1, N Takahashi, S Noguchi, H Suemori.   

Abstract

Hoxc-4 is a mouse homeobox gene located at the 3' end of the HoxC cluster. Of the HoxC genes, Hoxc-4 is expressed in the most anterior regions of the central nervous system and prevertebral column. To investigate its role in mouse development, we have generated Hoxc-4 mutant mice by gene targeting. Mice homozygous for the Hoxc-4 mutation are viable and fertile. Analysis of the skeletal system of homozygous mutants revealed various abnormalities in the cervical and thoracic regions. The most frequent abnormality was a partial posterior homeotic transformation of the seventh cervical vertebra. Less frequently, anterior transformations of the third and eighth thoracic vertebrae were observed. Furthermore, the xiphoid process of the sternum was malformed such that it had an aperture or a fissure. Although Hoxc-4 is expressed abundantly in the central nervous system, no obvious defects were observed. These results suggest that Hoxc-4 is required for specifying cervical and thoracic vertebral identity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626021     DOI: 10.1006/dbio.1996.0051

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  10 in total

1.  The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3' hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination.

Authors:  Edmund C Kim; Christopher R Edmonston; Xiaoping Wu; András Schaffer; Paolo Casali
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

Review 2.  Molecular basis for skeletal variation: insights from developmental genetic studies in mice.

Authors:  C Kappen; A Neubüser; R Balling; R Finnell
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2007-12

3.  A conserved role for Hox paralog group 4 in regulation of hematopoietic progenitors.

Authors:  Michelina Iacovino; Carmen Hernandez; Zhaohui Xu; Gagan Bajwa; Melissa Prather; Michael Kyba
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

Review 4.  Gene disruption in mice: models of development and disease.

Authors:  B S Shastry
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

5.  Altered pain responses in mice lacking alpha 1E subunit of the voltage-dependent Ca2+ channel.

Authors:  H Saegusa; T Kurihara; S Zong; O Minowa; A Kazuno; W Han; Y Matsuda; H Yamanaka; M Osanai; T Noda; T Tanabe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations.

Authors:  Heidi G Sutherland; Kathryn Newton; David G Brownstein; Megan C Holmes; Clémence Kress; Colin A Semple; Wendy A Bickmore
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

7.  Mutation of a ubiquitously expressed mouse transmembrane protein (Tapt1) causes specific skeletal homeotic transformations.

Authors:  Gareth R Howell; Mami Shindo; Stephen Murray; Thomas Gridley; Lawriston A Wilson; John C Schimenti
Journal:  Genetics       Date:  2006-12-06       Impact factor: 4.562

8.  Correlation between Hox code and vertebral morphology in the mouse: towards a universal model for Synapsida.

Authors:  Christine Böhmer
Journal:  Zoological Lett       Date:  2017-06-13       Impact factor: 2.836

9.  HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation.

Authors:  Seok-Rae Park; Hong Zan; Zsuzsanna Pal; Jinsong Zhang; Ahmed Al-Qahtani; Egest J Pone; Zhenming Xu; Thach Mai; Paolo Casali
Journal:  Nat Immunol       Date:  2009-04-12       Impact factor: 25.606

Review 10.  Developmental constraints on fin diversity.

Authors:  Alyssa Enny; Kathleen Flaherty; Shunsuke Mori; Natalie Turner; Tetsuya Nakamura
Journal:  Dev Growth Differ       Date:  2020-06-01       Impact factor: 2.053

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.